Clinical Research


 

Research & Innovation at Florida Medical Pain Management

Our doctors do more than practice medicine – they advance it! They seek new knowledge to improve therapies for people with chronic pain conditions.

Through research and clinical trials, we are developing new and better ways to prevent and treat disease.

Our research leads to better outcomes for you, including:

  • Shorter recovery times
  • More effective treatments
  • Fewer hospital visits
  • Minimally invasive procedures
  • Less side effects
  • And many others

We believe in taking a customized approach in the evaluation and treatment plan for each patient. Because no two patients are the same, our physicians suggest clinical trials specific to your needs and condition.

During the course of the clinical trial timely reassessment occurs, and the plan is adjusted based on your progress. We strive to work in partnership with you to achieve the best possible outcomes in terms of managing your pain and optimizing functionality.

Our clinical research team consists of:

  • Board certified doctors
  • Physician assistants
  • Nurse practitioners
  • Registered nurses
  • Certified clinical research coordinators

Our research department has been very successful in the past with subject recruitment on the other clinical studies. We currently have offices in New Port Richey, Springhill and the Saint Petersburg area with a fourth location soon to open in Clearwater Florida. We operate our research at one location, but we have access to the database for all three locations which consist of over 40,000 patients.


We work closely with a our multidisciplinary team members during a research study which include but are not limited to radiologist, psychiatrist, clinical nurses, social workers, community outreach, and referring physicians, IRB, FDA and more.

Our teams of research professionals are Good Clinical Practice (GCP) Certified and Shipment of Infectious Substance and Biological Materials (IATA) Certified.


Research Contact Information

Rita Ekwere

Research Manager

rekwere@fmpm.com

TEXT at (727)-280-6817  


Apply for a Study

Click on the button below to apply for a study now!

 

Apply Now




 

Previous Clinical Research Studies
  • Study of the Efficacy and Safety of XXXX in Subjects with Opioid-induced Bowel Dysfunction

  • Study With an Open-label Run-in to Assess the Efficacy and Safety of XXXX tablets 20 to 120 mg Once-daily in Subjects with moderate to Severe Chronic Low Back Pain

  • Study to Evaluate Effectiveness and Safety of a XXXX for the Treatment of Osteoarthritis of the Knee with Open Label Safety Extension

  • Study of XXXX in Patients with Lumbar Disc Herniation

  • Study of XXXX in Patients with Lumbar Disc Herniation (Phase III)

  • Trial Investigating the Efficacy and Safety of Intravenous XXXX in Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)

  • A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

  • Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-Dose Long-Term Opioid Analgesic Therapy For Chronic Pain

  • Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-Dose, Long-Term Opioid Analgesic Therapy for Chronic Pain as Measured by Quantitative Sensory Testing

  • Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects with a Recent History of Moderate to Severe Chronic Low Back Pain Currently Treated with Opioids

  • Study Comparing the Efficacy and Safety of 2 Dose-Regimens of TEV-48125 (1 Intravenous Administration, and 1 subcutaneous) Versus Placebo for the PreventionofChronic Cluster Headache (CCH)

  • Study Comparing the Efficacy and Safety of 2 Dose-Regimens of TEV-48125 ( 1 Intravenous Administration, and 1 subcutaneous) Versus Placebo for the Prevention of Episodic Cluster Headache (ECH)

  • Study to Explore the Long-Term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Prevention of Cluster Headache (LTSCH) 
  • Our Locations

    Choose your preferred location